Cynosure Receives Regulatory Approval to Market Elite(TM) Family of Workstations in China
June 26 2007 - 9:30AM
PR Newswire (US)
Company Expands Global Reach of Flagship System for Hair Removal
WESTFORD, Mass., June 26 /PRNewswire-FirstCall/ -- Cynosure, Inc.
(NASDAQ:CYNO), a leading developer and manufacturer of a broad
array of light-based aesthetic treatment systems, today announced
that it has received regulatory clearance to market and sell its
Elite(TM) family of laser workstations in China. "We are excited
about the opportunity to market and sell our Elite, Apogee 5500 and
Acclaim 7000 laser workstations in the fast-growing Chinese
market," said Cynosure President and Chief Executive Officer
Michael Davin. "As global demand for aesthetic laser procedures
continues to increase, and as Chinese consumers seek effective,
high-quality treatment options, we believe our Elite family of
products will provide a competitive solution for those seeking
laser cosmetic treatments." The Elite workstation combines the
Apogee 5500 system, which contains a short wavelength 755 nm
Alexandrite laser for lighter skin types, and the Acclaim 7000
system, which is equipped with a high-powered 1064 nm Nd:YAG laser
for use on tan and darker skin types to permanently remove hair.
The 5500 and 7000 systems can be sold as stand alone systems and
upgraded in the field to achieve the full versatility of the Elite.
In addition, the Elite can be used to treat benign epidermal
pigmented lesions such as age spots, sunspots and freckles, as well
as leg and facial veins. "Cynosure also has applied for regulatory
approvals in China for other current flagship products," Davin
said. "We expect that, upon approval, these products will allow us
to address additional opportunities in the Chinese market." In
December 2006, the company established a wholly-owned subsidiary in
China. About Cynosure, Inc. Cynosure, Inc. develops and markets
aesthetic treatment systems that are used by physicians and other
practitioners to perform non-invasive and minimally invasive
procedures to remove hair, treat vascular lesions, rejuvenate skin
through the treatment of shallow vascular and pigmented lesions,
laser lipolysis and temporarily reduce the appearance of cellulite.
Cynosure's products include a broad range of laser and other
light-based energy sources, including Alexandrite, pulsed dye,
Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure
was founded in 1991. For corporate or product information, contact
Cynosure at 800-886-2966, or visit http://www.cynosure.com/. Safe
Harbor This press release about future expectations, plans and
prospects for Cynosure in the People's Republic of China includes
forward-looking statements within the meaning of The Private
Securities Litigation Reform Act of 1995. These statements contain
the words "believes," "anticipates," "plans," "expects," "will" and
similar expressions. Actual results may differ materially from
those indicated by such forward-looking statements as a result of
various important factors, including Cynosure's history of
operating losses, its reliance on sole source suppliers, the
inability to accurately predict Cynosure's success in China,
changes in consumer preferences, competition in the aesthetic laser
industry as well economic, market, technological and other factors
discussed in Cynosure's most recent Annual Report on Form 10-K,
which is filed with the Securities and Exchange Commission. In
addition, the forward-looking statements included in this press
release represent Cynosure's views as of the date of this press
release. Cynosure anticipates that subsequent events and
developments will cause its views to change. However, while
Cynosure may elect to update these forward- looking statements at
some point in the future, it specifically disclaims any obligation
to do so. These forward-looking statements should not be relied
upon as representing Cynosure's views as of any date subsequent to
the date of this press release. Contact: Scott Solomon Vice
President Sharon Merrill Associates, Inc. 617.542.5300 DATASOURCE:
Cynosure, Inc. CONTACT: Scott Solomon, Vice President, Sharon
Merrill Associates, Inc., +1-617-542-5300, Web site:
http://www.cynosure.com/
Copyright
Cynosure (NASDAQ:CYNO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cynosure (NASDAQ:CYNO)
Historical Stock Chart
From Jul 2023 to Jul 2024